Sang Won Kim
Papers
2
Total Citations
14
H-Index
2
About
Dr. Sang Won Kim is a pioneering urologic surgeon and researcher whose work centers on advancing prostate cancer detection and surgical outcomes. His major contributions include demonstrating that the use of 5-alpha reductase inhibitors (5ARIs) can improve prostate cancer detection rates by creating more opportunities for repeated PSA testing—a finding with significant implications for screening strategies, particularly in populations with low PSA uptake. This decade-long nationwide observational study in Korea (2007–2016) has informed clinical practice by highlighting how medication-driven PSA monitoring can enhance early diagnosis. Dr. Kim has also made a transformative impact on surgical technique, showing that the extraperitoneal approach using the da Vinci SP robotic platform achieves faster operative times and superior functional recovery compared to traditional transperitoneal multiport surgery. His 2024 paper on this topic has already garnered 12 citations, reflecting its immediate influence on the field. By integrating innovative surgical methods with population-level screening insights, Dr. Kim is shaping the future of prostate cancer management—from detection through recovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2